Early relief of upper gastrointestinal dyspeptic symptoms: A survey of empirical therapy with pantoprazole in Canadian clinical practice

Canadian Journal of Gastroenterology

Volumn 16, Issue 7, 2002, Pages 439-450

  Armstrong, David ^a   Kazim, Farouk ^a   Gervais, Marcel ^a   Pyzyk, Myron ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Acid related symptoms; Dyspepsia; Gastroesophageal reflux disease; Pantoprazole; Proton pump inhibitor; Upper gastrointestinal dyspeptic symptoms

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CANADA; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE SEVERITY; DOSE RESPONSE; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HEALTH SURVEY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOMES RESEARCH; PEPTIC ULCER; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SCORING SYSTEM; UPPER GASTROINTESTINAL TRACT;

EID: 0036633984     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/567684     Document Type: Article

References (30)

1. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: Findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study
2. Canadian physician survey of dyspepsia management
3. An evidence based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
4. Functional gastroduodenal disorders
5. The endoscopic assessment of esophagitis: A progress report on observer agreement
6. An evidence-based appraisal of reflux disease management: The Genval Workshop Report
7. Functional dyspepsia: A classification with guidelines for diagnosis and management
8. Management of dyspepsia: Report of a working party
9. Predicting endoscopic diagnosis in the dyspeptic patient: The value of clinical judgement
10. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease
11. Consensus Conference participants. Canadian Helicobacter pylori Consensus Conference
12. Canadian Helicobacter pylori consensus conference update: Infection in adults
13. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy
14. Relationship between symptoms, endoscopic findings and treatment outcome in reflux esophagitis
15. Dyspepsia and dyspepsia subgroups in Japan: Symptom profiles and experience with cisapride
16. Upper gastrointestinal symptoms in general practice: A multicentre UK study
17. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia
18. What is behind dyspepsia?
19. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia
20. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized, controlled trial
21. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis
22. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice
23. Heartburn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response
24. Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole
25. Treating the symptoms of gastro-oesophageal reflux disease: A double-blind comparison of omeprazole and cisapride
26. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: A multicentre study in general practice
27. The management of acid-related dyspepsia in general practice: A comparison of an omeprazole versus antacid-alginate/ranitidine management strategy
28. Antisecretory therapy in 1017 patients with ulcer-like or reflux-like dyspepsia in general practice
29. A double-blind, randomised controlled trial comparing omeprazole, ranitidine, cisapride and placebo in 512 Helicobacter pylori (Hp) negative primary care patients with uninvestigated dyspepsia (UD) - The CADET-HN Study
30. Upper gastrointestinal symptoms and quality of life: The effect of acid suppression